Anti-angiogenic agent

0 marketed 2 in Phase 2

This page covers all Anti-angiogenic agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting VEGF.

Targets

Phase 2 pipeline (2)

Anti-VEGF injections · Bayer · Oncology
Anti-VEGF injections work by binding to and inhibiting vascular endothelial growth factor (VEGF), a protein that promotes angiogenesis.
Anti-VEGF treatment · Vastra Gotaland Region · Oncology
Anti-VEGF treatment works by inhibiting the vascular endothelial growth factor (VEGF) pathway, which is involved in angiogenesis and tumor growth.